Biotech/Health
•2 min read
AstraZeneca Inks $1.5B AI Drug Discovery Deal With insitro
Zubiqo Take
“Like most AI pharma pacts, the massive $1.5B headline figure obscures the reality that AstraZeneca is only risking $40M in actual cash upfront, effectively buying a relatively cheap call option on insitro's machine learning models finding viable targets.”
Mag 7
Fierce Biotech